1. Home
  2. NGVC vs STTK Comparison

NGVC vs STTK Comparison

Compare NGVC & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Grocers by Vitamin Cottage Inc.

NGVC

Natural Grocers by Vitamin Cottage Inc.

HOLD

Current Price

$27.80

Market Cap

736.2M

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$7.18

Market Cap

683.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGVC
STTK
Founded
1955
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
736.2M
683.8M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
NGVC
STTK
Price
$27.80
$7.18
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$36.00
$10.00
AVG Volume (30 Days)
122.5K
1.2M
Earning Date
05-07-2026
05-01-2026
Dividend Yield
2.16%
N/A
EPS Growth
36.05
53.02
EPS
1.54
N/A
Revenue
N/A
$1,000,000.00
Revenue This Year
$7.08
N/A
Revenue Next Year
$6.04
N/A
P/E Ratio
$17.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.47
$0.76
52 Week High
$41.58
$8.33

Technical Indicators

Market Signals
Indicator
NGVC
STTK
Relative Strength Index (RSI) 38.01 54.43
Support Level $24.66 $5.87
Resistance Level $30.47 $7.75
Average True Range (ATR) 1.51 0.50
MACD -0.59 -0.04
Stochastic Oscillator 22.71 53.26

Price Performance

Historical Comparison
NGVC
STTK

About NGVC Natural Grocers by Vitamin Cottage Inc.

Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories: natural and organic food, dietary supplements, natural body care, household, pet care products, books, and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business is conducted. The company generates the majority of its revenue from grocery products and dietary supplements, and the rest from other products.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: